Costacurta M, Vervoort SJ, Hogg SJ, Martin BP, Johnstone RW, Shortt J. Whole genome CRISPR screening identifies TOP2B as a potential target for IMiD sensitization in multiple myeloma. haematol [Internet]. 2021Jul.1 [cited 2024Apr.19];106(7):2013-7. Available from: https://haematologica.org/article/view/haematol.2020.265611